Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 95.00M | € 116.30M | € 99.20M | € 201.00M | € 89.60M |
Total Assets | € 3.15B | € 2.98B | € 2.83B | € 2.78B | € 2.62B |
Total Debt | € 443.30M | € 469.50M | € 398.90M | € 515.40M | € 516.80M |
Net Debt | € 348.30M | € 353.20M | € 299.70M | € 314.40M | € 427.20M |
Total Liabilities | - | € 1.32B | € 1.25B | € 1.23B | € 1.15B |
Stockholders Equity | € 1.74B | € 1.66B | € 1.58B | € 1.55B | € 1.46B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |